Annual Report 2015 of GlaxoSmithKline (GSK) Bangladesh Limited

It is a broadly described annual report of GlaxoSmithKline (GSK) Bangladesh Limited in the year of 2015. During the year 2015, GlaxoSmithKline Bangladesh Limited contributed to the government exchequer a sum of Taka. 1,961 million. Net Sales of the Company was Tk. 6.699 million against Tk. 7,181 million of last year. Net Profit after Tax for the year Taka. 831,079 million. EPS (Earnings per Share) has marginally increased to Tk. 68.99 from 1k. 68.63 in 2014.

The Board of Directors has recommended a final dividend of 550% Le. Tk. 55.00 per share of Tk. 10.00 each for the year 2015. These financial statements are presented in Bangladesh Taka (Taka/Tk/BDT) which is the company’s functional currency. All financial information presented in Taka has been rounded off to the nearest Taka.

More Annual Report of GlaxoSmithKline (GSK) Bangladesh Limited:

  1. Annual Report 2013 of GlaxoSmithKline (GSK) Bangladesh Limited
  2. Annual Report 2014 of GlaxoSmithKline (GSK) Bangladesh Limited
  3. Annual Report 2015 of GlaxoSmithKline (GSK) Bangladesh Limited
  4. Annual Report 2016 of GlaxoSmithKline (GSK) Bangladesh Limited